| abstract |
The present invention relates to neuropeptide-2 receptor agonists of formula (I) and pharmaceutically acceptable salts, derivatives and fragments thereof. Such compounds and pharmaceutical compositions containing them are useful for the treatment of diseases such as, for example, obesity and diabetes: Formula I YR 1 -R 2 -XR 3 -R 4 -R 5 -R 6 -R 7 -R 8 -R 9 -R 10 -R 11 -R 12 -R 13 -R 14 -NH 2 Where Substituents are as disclosed in the specification. |